HomeProductsBioactive CompoundsProtein Kinase TargetsEphrin ReceptorJi-101
Chemical structure of CAS 900573-88-8

Ji-101

In Stock•Starting at $164 for 50 mg•Purity ≥ 99%
CAS No.900573-88-8
MDL No.MFCD26142530
MFC22H20BrN5O2
MW466.30
InChI KeyZXBFYBLSJMEBEP-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
50 mg99%$164In Stock
100 mg99%$276In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.900573-88-8
Product NameJi-101

Biological Targets

EPHB4·PDGFRB·KDR

Associated Conditions

malignant colon neoplasm·ovarian cancer·neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Pharmacokinetics, tissue distribution and identification of putative metabolites of JI-101 - a novel triple kinase inhibitor in rats.

Arzneimittel-Forschung • Vol. 62, Issue 1 • 2012
PMID: 22331760DOI: 10.1055/s-0031-1295427

A strategy for extending the applicability of a validated plasma calibration curve to quantitative measurements in multiple tissue homogenate samples: a case study from a rat tissue distribution study of JI-101, a triple kinase inhibitor.

Biomedical chromatography : BMC • Vol. 26, Issue 4 • 2012
PMID: 21877323DOI: 10.1002/bmc.1680

Highly sensitive method for the determination of JI-101, a multi-kinase inhibitor in human plasma and urine by LC-MS/MS-ESI: method validation and application to a clinical pharmacokinetic study.

Biomedical chromatography : BMC • Vol. 26, Issue 2 • 2012
PMID: 21594880DOI: 10.1002/bmc.1652

Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.

Biomedical chromatography : BMC • Vol. 25, Issue 7 • 2011
PMID: 20872957DOI: 10.1002/bmc.1518

Documentation